Discuss Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
From BugSigDB
the sample sizes of the groups in experiment 2 (Progressive- Free- Survival more less than 30 days, and Progressive -Free- Survival more than 30 days) were not clearly stated. However, the experiment was carried out in the entire cohort which has sample size of 100
Start a discussion about Study 326
Talk pages are where people discuss how to make content on BugSigDB the best that it can be. You can use this page to start a discussion with others about how to improve Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors.
